Novavax, Inc.NVAXNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank71
3Y CAGR-33.0%
5Y CAGR+0.3%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
-33.0%/yr
vs +94.1%/yr prior
5Y CAGR
+0.3%/yr
Recent deceleration
Acceleration
-127.1pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
3 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$147.30M-56.3%
2024$337.19M-28.1%
2023$468.95M-4.0%
2022$488.69M+63.8%
2021$298.36M+105.4%
2020$145.29M+322.1%
2019$34.42M+0.0%
2018$34.41M-0.1%
2017$34.45M-26.0%
2016$46.53M-